Category-thesis founders
You believe the category needs a specific formula nobody is selling, and you have the audience to test it. You need an engineer-grade brief, not a marketing deck.
Most operators try to brief a factory with a Pinterest board, a competitor screenshot, and a price target. The factory politely ghosts. Formula development is the document discipline that fixes this — a one-page spec dense enough that any GMP-aware co-manufacturer can quote it in two days, a stability and compatibility review that catches expensive mistakes before tooling fires, and an ingredient sourcing matrix with at least two backup vendors per input so a single delisting does not kill your launch. It sits upstream of private label and contract manufacturing. Without it, every quote you get is wrong by 20-40 percent.
Buyers conflate these. The factory does not. Here is the real spread.
| Formula Development | Private Label | Contract Manufacturing | |
|---|---|---|---|
| Who owns the formula | You — built from scratch | The factory — you license | You — and the factory runs it exclusively |
| Time to first inventory | Output goes into PL or CM (8-22wk after this) | 6-10 weeks total | 14-22 weeks total |
| Up-front investment | $1,500-$5,000 for stock-formula tweaks; $8,000-$25,000 for true custom | Often $0 (formula is sunk by the factory) | Includes formula dev cost |
| Defensibility | Moderate — depends on IP scope | Low — competitors can clone the SKU | High — you own the recipe |
You believe the category needs a specific formula nobody is selling, and you have the audience to test it. You need an engineer-grade brief, not a marketing deck.
Your second or third SKU has to be defensible. A stock formula will not differentiate. You need IP you can put on a deck for retail buyers.
You have proven category traction on a stock formula. Margin is shrinking because three competitors source the same SKU. Formula dev is the upgrade path.
30-min strategy call. We pull together claim ambitions, target retail price, channel mix, allergen and certification asks, and the regulatory market (US, EU, Canada) the SKU has to pass.
Formulator builds usage rates against your claim ambition. We validate dosages against published research and industry-standard upper limits. Sourcing matrix lands with two backup vendors per input.
Bench-scale samples with accelerated stability (40°C/75% RH, six-week walk-down). Compatibility flags for any pair that browns, separates, or shifts pH. Real custom programs add 8-12 weeks of full ICH stability.
Three-quote cost model at 500/1,000/5,000 units across two facility candidates. Final spec sheet is ready to RFP. You walk into private label or contract manufacturing with a brief that gets quoted same-week.
// TotalStock-formula tweaks 4-6 weeks. Bench-scale custom 10-12 weeks. Full custom with ICH stability 14-20 weeks.
Formula development is the cheapest line item that, done badly, makes every other line item expensive. Skipping it does not save money — it pushes the cost into change orders during production, which is where margin goes to die.
| Format | First-run MOQ | Reorder MOQ | Lead time |
|---|---|---|---|
| Capsule formula (stock base) | — | — | 4-6wk dev |
| Custom capsule formula | — | — | 10-12wk dev |
| Gummy formula (custom) | — | — | 12-16wk dev |
| Beverage formula (shelf-stable) | — | — | 14-20wk dev |
| Topical / serum formula | — | — | 10-14wk dev |
/ All ranges are typical industry figures. Final unit cost depends on fill weight, container, label, certifications, run size. Quote against your specific brief.
Every line below has cost a real operator real money. We have seen each of them. Here is the tell, and the fix.
// Tell
Bench-scale sample tastes great, first 1,000-unit pilot does not. Usually a homogeneity or texture issue from process scale-up.
// Fix
Insist on a pilot run before full PO. Spec the homogenization parameters, not just the formula. Pay for the pilot — it is cheaper than a 5,000-unit recall.
// Tell
Vendor stops supplying, prices double, or COA changes. Your facility hits pause. You discover this from an email, not a phone call.
// Fix
Sourcing matrix with two backup vendors per input. Approve the backups during formula dev — not when the line is down.
// Tell
Marketing wrote 'clinically proven' on the deck. Regulatory said no. Now the formula has to add a study-backed dose, which changes cost and stability.
// Fix
Lock the claim language during formula dev — before bench scale. The dose goes in the deck before the label goes to print.
// Tell
Six-week accelerated walk-down shows breakdown of an active. Shelf life shrinks from 24 months to 9. Retail buyer pulls.
// Fix
Run accelerated stability before printing labels. If you must print early, set conservative shelf-life on label and update on reorder.
Formula development is not certified. The facility that runs the formula carries the certifications. We design the spec so it can pass at any reputable cGMP-registered, NSF-audited, or USDA Organic-certified facility on the candidate list.
FDA's regulation of current Good Manufacturing Practice for dietary supplements. Defines records, identity testing, and process controls.
View source →Voluntary standard verifying contents, purity, and contaminant limits. Used by reputable retailers and pro-sport channels.
View source →International cosmetic GMP standard. Required by major EU and US retailers for cosmetic SKUs.
View source →/ All citations verified against the issuing body's published page. Last verified: 2026-05-10.
Six fields. We come back inside 36 hours with three sourcing routes — MOQ, lead time, indicative cost on each.
Open quote form → [02] ToolThe one-page brief format any GMP-aware factory will quote against in 48 hours. Free.
Download PDF →We'll come back inside 36 hours with three sourcing routes, MOQ + lead time + indicative cost on each.